Evidence map›Paper›PMID 30966035›Full record

ArticlePolymers2017

Immobilization of Platelet-Rich Plasma onto COOH Plasma-Coated PCL Nanofibers Boost Viability and Proliferation of Human Mesenchymal Stem Cells.

Anastasiya Solovieva, Svetlana Miroshnichenko, Andrey Kovalskii, Elizaveta Permyakova, Zakhar Popov, Eva Dvořáková, Philip Kiryukhantsev-Korneev, Aleksei Obrosov, Josef Polčak, Lenka Zajíčková and 2 more

Abstract read
In one paragraph

Article in Polymers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Advances with Platelet-Rich Plasma for Bone Healing.Biologics : targets & therapy · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Apolipoprotein A-I Supports MSCs Survival under Stress Conditions.International journal of molecular sciences · 2020
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anastasiya SolovievaScientific Institute of Clinical and Experimental Lymphology-Branch of the ICG SB RAS, 2 Timakova str., 630060 Novosibirsk, Russia. solovevaao@gmail.com.
Svetlana MiroshnichenkoScientific Institute of Clinical and Experimental Lymphology-Branch of the ICG SB RAS, 2 Timakova str., 630060 Novosibirsk, Russia. svmiro@yandex.ru.
Andrey KovalskiiNational University of Science and Technology "MISiS", Leninsky pr. 4, 119049 Moscow, Russia. andreykovalskii@gmail.com.
Elizaveta PermyakovaNational University of Science and Technology "MISiS", Leninsky pr. 4, 119049 Moscow, Russia. permyakova.elizaveta@gmail.com.ORCID 0000-0003-2581-0803
Zakhar PopovNational University of Science and Technology "MISiS", Leninsky pr. 4, 119049 Moscow, Russia. zipcool@bk.ru.
Eva DvořákováRG Plasma Technologies, CEITEC⁻Central European Institute of Technology, Masaryk University, Purkyňova 123, 61200 Brno, Czech Republic. evke.kedronova@gmail.com.
Philip Kiryukhantsev-KorneevNational University of Science and Technology "MISiS", Leninsky pr. 4, 119049 Moscow, Russia.
Aleksei ObrosovChair of Physical Metallurgy and Materials Technology, Brandenburg Technical University, 03046 Cottbus, Germany. aleksei.obrosov@b-tu.de.ORCID 0000-0001-6343-7523
Josef PolčakCEITEC-Central European Institute of Technology, Brno University of Technology, Technická 3058/10, 61600 Brno, Czech Republic. polcak@fme.vutbr.cz.
Lenka ZajíčkováRG Plasma Technologies, CEITEC⁻Central European Institute of Technology, Masaryk University, Purkyňova 123, 61200 Brno, Czech Republic. lenkaz@physics.muni.cz.ORCID 0000-0002-6906-8906
Dmitry V ShtanskyNational University of Science and Technology "MISiS", Leninsky pr. 4, 119049 Moscow, Russia. shtansky@shs.misis.ru.ORCID 0000-0001-7304-2461
Anton ManakhovNational University of Science and Technology "MISiS", Leninsky pr. 4, 119049 Moscow, Russia. ant-manahov@ya.ru.ORCID 0000-0003-4517-1682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The scaffolds made of polycaprolactone (PCL) are actively employed in different areas of biology and medicine, especially in tissue engineering. However, the usage of unmodified PCL is significantly restricted by the hydrophobicity of its surface, due to the fact that its inert surface hinders the adhesion of cells and the cell interactions on PCL surface. In this work, the surface of PCL nanofibers is modified by Ar/CO₂/C₂H₄ plasma depositing active COOH groups in the amount of 0.57 at % that were later used for the immobilization of platelet-rich plasma (PRP). The modification of PCL nanofibers significantly enhances the viability and proliferation (by hundred times) of human mesenchymal stem cells, and decreases apoptotic cell death to a normal level. According to X-ray photoelectron spectroscopy (XPS), after immobilization of PRP, up to 10.7 at % of nitrogen was incorporated into the nanofibers surface confirming the grafting of proteins. Active proliferation and sustaining the cell viability on nanofibers with immobilized PRP led to an average number of cells of 258 ± 12.9 and 364 ± 34.5 for nanofibers with ionic and covalent bonding of PRP, respectively. Hence, our new method for the modification of PCL nanofibers with PRP opens new possibilities for its application in tissue engineering.

Indexed as

cell viabilityCOOH plasmananofibersplatelet-rich plasmapolycaprolactonePRP immobilization

Identifiers

PMID30966035
PMCPMC6418517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.